Market movers: Levi's, Applied Digital, Starbucks, Graphene Manufacturing
Levi's (LEVI) shares fell 3.7% after softer DTC sales growth, though earnings beat estimates. Starbucks (SBUX) dropped 3% amid takeover speculation. Argenx (ARGX) fell 15% after discontinuing a drug trial. Haemonetics (HAE) rose 13% on CSL's device rollout plan. Tilray (TLRY) reported record revenue. Wolfspeed (WOLF) gained 11% on a $1.5B US DoD loan. Palantir (PLTR) rose 3% after a Goldman upgrade. Globalfoundries (GFS) rose 3% on a $2B TSMC deal. Helen of Troy (HELE) raised its profit outlook.
How this was made
The 30-second read
Why it matters
Overall market sentiment is mixed, with biotech and consumer stocks reacting to earnings and contract news, while industrial and tech names see positive financing and partnership developments.
Market read
Multiple individual catalysts drive short‑term volatility across sectors; no single macro theme dominates.
What to watch
Potential longer‑term benefits from Starbucks' acquisition talks and Haemonetics' partnership with CSL could outweigh short‑term sell pressure.
Background
The article aggregates several same‑day price moves and corporate updates across a range of sectors.
Ticker impact
Levi Strauss shares fell 3.7% after Q3 direct-to-consumer sales growth missed expectations.
downward pressure from earnings miss
Earnings miss with lower sales growth drives short-term sell-off.
Starbucks shares dropped over 3% after FT reported advisers working on a potential $39 billion takeover of Chipotle.
downward pressure from takeover uncertainty
Deal speculation and valuation risk cause sell pressure.
argenx shares fell nearly 15% after discontinuing a late‑stage trial of Vyvgart for Sjögren's disease.
downward pressure from trial halt
Trial failure is material for biotech valuation.
Haemonetics shares jumped over 13% after CSL announced a timetable to move its US plasma collection centers onto Haemonetics devices.
upward pressure from new contract
Large customer adoption drives revenue outlook.
Tilray reported record Q1 revenue of $257.1 million, up 23% year‑over‑year.
potential upward pressure from earnings beat
Revenue beat signals improving market position.
Wolfspeed shares opened 11% higher after the U.S. Department of War conditionally agreed to lend up to $1.5 billion.
upward pressure from financing news
Large government financing is a material catalyst.
Palantir rose over 3% after Goldman Sachs upgraded the stock to ‘buy’ from ‘neutral’.
upward pressure from upgrade
Upgrade signals improved outlook.
Globalfoundries shares rose over 3% after announcing a multiyear $2 billion agreement with TSMC to expand advanced packaging capacity.
upward pressure from contract win
Large TSMC deal enhances revenue pipeline.
Market effects
Consumer discretionary and biotech sectors see mixed moves; earnings and contract news drive volatility.
U.S. markets impacted by multiple earnings and contract announcements; limited global spillover.
Limited to U.S. listed companies; no broad macro impact.
Counterpoint
Some stocks may rebound as initial overreactions fade, especially Levi and Starbucks.
Key entities
- companyLevi Strauss & Co
Denim maker reporting weaker DTC sales.
- companyStarbucks Corp
Coffee chain linked to potential Chipotle takeover.
- companyargenx SE
Biotech halting a late‑stage trial.
- companyHaemonetics
Medical device maker gaining CSL contract.
- companyTilray Inc
Cannabis firm posting record revenue.
